BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

NCT01782209 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2020-07-28

Study results available
· View outcomes & findings →

Summary

The objectives of this study is to establish the natural history of BK virus viremia and other possible opportunistic viral pathogens in renal transplants recipients.

Conditions

  • BK Virus (BKV) Viremia

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Richard J Whitley, MD · University of Birmingham at Alabama

  • John W Gnann, MD · Medical University of South Carolina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01782209 on ClinicalTrials.gov